FOXM1 and central nervous system cancer: Based on the findings, one reasonable hypothesis is that FoxM1 activity is mitigated by N-terminal autorepression, which can be destabilized with R15, contributing to the transcriptional activation, nuclear translocation and malignant function of FoxM1 in glioma cells.